Healio

Early ID consult improves outcomes for hospitalized patients

Please provide your email address to receive an email when new articles are posted on . “Previous studies in the United States have been limited to individual centers or infections, or to Medicare ...
Healio

ID consult improves outcomes for patients with gram-negative BSI

Please provide your email address to receive an email when new articles are posted on . Patients with gram-negative BSI who received an infectious disease consultation had a lower risk for 30- and ...
ascopubs.org

Identification of multifunctional cytotoxic T-cell subsets as immune correlates with clinical outcomes in a phase II study of AGS-003, an autologous dendritic cell-based ...

Comparison of SearchLight and Luminex multiplex assays: A case study of 27 cytokines in 156 melanoma blood serum samples. This is an ASCO Meeting Abstract from the Markers in Cancer. This abstract ...
ascopubs.org

Outcomes of invasive ductal (ID) or invasive lobular (IL) early stage breast cancer in women treated with anastrozole or exemestane in the Canadian cancer trials Group MA.27.

A phase II study of the PI3K inhibitor taselisib (GDC-0032) combined with fulvestrant (F) in patients (pts) with HER2-negative (HER2-), hormone receptor-positive (HR+) advanced breast cancer (BC).
The Lancet

Support without identification: a regressive shift in neurodevelopmental care?

Contrary to English and Scottish Government policies, which convey an expectation that people who might be neurodivergent can request an assessment through the National Health Service (NHS), services ...